{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:23:25Z","timestamp":1790857405809,"version":"4.1.0"},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T00:00:00Z","timestamp":1133222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Scand J Immunol"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p> <jats:italic>Mycobacterium bovis<\/jats:italic> bacillus Calmette\u2010Gu\u00e9rin (BCG) is capable of directly stimulating several effector functions of human natural killer (NK) cells in the absence of interleukin\u201012 and professional antigen presenting cells. To assess the contribution of two main human NK\u2010cell subsets (CD56<jats:sup>dim<\/jats:sup> and CD56<jats:sup>bright<\/jats:sup>) to the overall <jats:italic>in vitro<\/jats:italic> NK\u2010cell response to BCG, peripheral blood mononuclear cells depleted of nylon wool\u2010adherent cells or purified NK cells were stimulated with live BCG. By combining intranuclear bromodeoxyuridine (BrdU) staining and analysis of CD56 marker intensity, statistically higher percentages of BrdU<jats:sup>+<\/jats:sup> cells were found among the CD56<jats:sup>bright<\/jats:sup> subset than the CD56<jats:sup>dim<\/jats:sup> subset after 6 days of stimulation with BCG. Similarly, evaluation of intracellular interferon\u2010\u03b3 (IFN\u2010\u03b3) revealed that CD56<jats:sup>bright<\/jats:sup> cells were those mainly involved in IFN\u2010\u03b3 production in response to BCG. In contrast, the CD56<jats:sup>dim<\/jats:sup> subset contained higher levels of perforin and granzyme A, two key molecules for exocytosis\u2010mediated cytotoxicity, than the CD56<jats:sup>bright<\/jats:sup> subset. Although 16\u201320\u2010h stimulation with BCG did not substantially alter the expression of cytotoxic molecules by the two subsets, a decrease in perforin content was observed in the CD56<jats:sup>dim<\/jats:sup>, but not in the CD56<jats:sup>bright<\/jats:sup> subset, following 4\u2010h incubation with the NK\u2010sensitive target K562 cell line. This decrease in perforin content correlated with the induction by BCG\u2010stimulated NK cells, of early markers of apoptosis on target cells to a greater extent than unstimulated cells suggesting a major role for the CD56<jats:sup>dim<\/jats:sup> subset in cytotoxic activity in response to BCG. Taken together, these results demonstrate that CD56<jats:sup>bright<\/jats:sup> and CD56<jats:sup>dim<\/jats:sup> human NK\u2010cell subsets exert different functional activities in response to a live bacterial pathogen.<\/jats:p>","DOI":"10.1111\/j.1365-3083.2005.01692.x","type":"journal-article","created":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T17:15:06Z","timestamp":1133284506000},"page":"498-506","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Human CD56<sup>bright<\/sup> and CD56<sup>dim<\/sup> Natural Killer Cell Subsets Respond Differentially to Direct Stimulation with <i>Mycobacterium bovis<\/i> Bacillus Calmette\u2010Gu\u00e9rin"],"prefix":"10.1111","volume":"62","author":[{"given":"G.","family":"Batoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Esin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Favilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bottai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Maisetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Florio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Campa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,11,29]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60664-1"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(01)02060-9"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(93)90030-V"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.10.3146"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.143.10.3183"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2876"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.3.1455"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200425100"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2820"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2004.01858.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1996.d01-691.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1128\/IAI.67.8.3800-3809.1999","article-title":"In vitro expansion of T cell receptor V\u03b123+ CD4+ T lymphocytes in HLA\u2010DR17(3) DQ2+ individuals upon stimulation with Mycobacterium tuberculosis","volume":"67","author":"Esin S","year":"1999","journal-title":"Infect Immun"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0039.2002.590301.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015476114409"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02523.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200103)31:3<792::AID-IMMU792>3.0.CO;2-U"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118321"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(99)00011-1"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01137.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1462-5822.2003.00351.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1128\/iai.60.7.2843-2849.1992","article-title":"Mycobacterial induction of activated killer cells: possible role of tyrosine kinase activity in interleukin\u20102 receptor alpha expression","volume":"60","author":"Blanchard DK","year":"1992","journal-title":"Infect Immun"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.2.752-759.2000"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1128\/iai.56.6.1436-1441.1988","article-title":"Natural killer cell activation and interferon production by peripheral blood lymphocytes after exposure to bacteria","volume":"56","author":"Klimpel GR","year":"1998","journal-title":"Infect Immun"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2003.02096.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1128\/iai.59.8.2767-2773.1991","article-title":"Potentiation of human natural killer cell cytotoxicity by Salmonella bacteria is an interferon\u2010 and interleukin\u20102\u2010independent process that utilizes CD2 and CD18 structures in the effector phase","volume":"59","author":"Tarkkanen J","year":"1991","journal-title":"Infect Immun"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.3109\/08820139509066846"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116161"}],"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3083.2005.01692.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3083.2005.01692.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T17:21:18Z","timestamp":1697304078000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3083.2005.01692.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,29]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1365-3083.2005.01692.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3083.2005.01692.x","archive":["Portico"],"relation":{},"ISSN":["0300-9475","1365-3083"],"issn-type":[{"value":"0300-9475","type":"print"},{"value":"1365-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,29]]},"assertion":[{"value":"2005-11-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}